Efficient Production of the PET Radionuclide <sup>133</sup>La for Theranostic Purposes in Targeted Alpha Therapy Using the <sup>134</sup>Ba(p,2n)<sup>133</sup>La Reaction
Targeted Alpha Therapy is a research field of highest interest in specialized radionuclide therapy. Over the last decades, several alpha-emitting radionuclides have entered and left research topics towards their clinical translation. Especially, <sup>225</sup>Ac provides all necessary ph...
Saved in:
Main Authors: | Santiago Andrés Brühlmann (Author), Martin Kreller (Author), Hans-Jürgen Pietzsch (Author), Klaus Kopka (Author), Constantin Mamat (Author), Martin Walther (Author), Falco Reissig (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cyclotron-Based Production of <sup>67</sup>Cu for Radionuclide Theranostics via the <sup>70</sup>Zn(p,α)<sup>67</sup>Cu Reaction
by: Santiago Andrés Brühlmann, et al.
Published: (2023) -
Nuclear Cross-Section of Proton-Induced Reactions on Enriched <sup>48</sup>Ti Targets for the Production of Theranostic <sup>47</sup>Sc Radionuclide, <sup>46c</sup>Sc, <sup>44m</sup>Sc, <sup>44g</sup>Sc, <sup>43</sup>Sc, and <sup>48</sup>V
by: Liliana Mou, et al.
Published: (2023) -
Radionuclide Cisternography with [<sup>64</sup>Cu]Cu-DOTA
by: Julia Greiser, et al.
Published: (2023) -
Multimodal Radiobioconjugates of Magnetic Nanoparticles Labeled with <sup>44</sup>Sc and <sup>47</sup>Sc for Theranostic Application
by: Perihan Ünak, et al.
Published: (2023) -
Lutathera<sup>®</sup>: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy
by: Ute Hennrich, et al.
Published: (2019)